News for Healthier Living
MSK Research Highlights, December 18, 2024
New research from Memorial Sloan Kettering Cancer Center (MSK) uncovers clues about how cells control a key DNA repair protein; develops a new method for studying gene amplifications in cancer; sheds new light on tumor suppressor genes; shows MSK-IMPACT(r) could be used for HLA genotype screening to predict response to cellular therapies; identifies a possible strategy to overcome immune evasion in ovarian cancer; and finds strong support for telemedicine visits among cancer patients.
December 18, 2024
December 30 2024December 29 2024December 28 2024December 27 2024December 26 2024December 24 2024December 23 2024December 21 2024December 20 2024December 19 2024December 18 2024December 17 2024December 16 2024
|
|
|
|
|